SYDNEY, Australia, January 14, 2008-Biotechnology company Arana Therapeutics Limited (ASX: AAH, AIM: AAHx) today announced that it had acquired 171,606 shares at a cost of $199,139 in on-market transactions to fulfil allocations of shares to certain employees under the rules of the performance share plan.
